Literature DB >> 33533664

Phenotypic assessment of liver-derived cell cultures during in vitro expansion.

Razvan Iacob1,2,3, Vlad Herlea1,2,4, Lorand Savu1,4, Ioana R Florea1,4,5, Veronica M Ilie1,4,5, George Terinte-Balcan6, Mihaela Gherghiceanu6, Mihaela Uta1, Codruta Popa1,3, Speranta Iacob1,2,3, Ioan V Matei4, Cerasela Jardan3, Daniela Lixandru1,3, Simona Dima1,2,4, Irit Meivar-Levy4,7,8, Sarah Ferber4,7,8,9, Irinel Popescu1,2,4.   

Abstract

Background: Liver cells represent an attractive source of cells for autologous regenerative medicine. The present study assesses the liver cells' stability during in vitro expansion, as a prerequisite for therapeutic use.
Results: The human liver cell cultures in this study were propagated efficiently in vitro for at least 12 passages. No significant changes in morphology, intracellular ultrastructures and characteristic markers expression were found during in vitro expansion of cells from all analyzed donors. However, expanded cells derived from male donors of >60 years old, lost the Y chromosome.
Conclusion: Liver-derived cell cultures adopt a proliferative, stable mesenchymal phenotype, through an epithelial to mesenchymal transition process. The molecular and phenotypic changes of the cells during propagation are uniform, despite the heterogeneity of the different donors. Loss of Y chromosome occurs after cells' propagation in elder male donors.

Entities:  

Keywords:  cell therapy; epithelial to mesenchymal transition; liver-derived mesenchymal cells

Year:  2021        PMID: 33533664     DOI: 10.2217/rme-2020-0093

Source DB:  PubMed          Journal:  Regen Med        ISSN: 1746-0751            Impact factor:   3.806


  1 in total

1.  The role of DNA demethylation in liver to pancreas transdifferentiation.

Authors:  Adi Har-Zahav; Daniela Lixandru; David Cheishvili; Sarah Ferber; Simona Olimpia Dima; Ioan Valentin Matei; Ioana Raluca Florea; Veronica Madalina Aspritoiu; Inna Blus-Kadosh; Irit Meivar-Levy; Andreea Madalina Serban; Irinel Popescu; Moshe Szyf
Journal:  Stem Cell Res Ther       Date:  2022-09-16       Impact factor: 8.079

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.